Events Archives - Page 44 of 128

1 minute read

Iovance Biotherapeutics To Present Clinical And Pre-Clinical Data For Tumor Infiltrating Lymphocyte Therapies At Society For Tumor Immunotherapy Of Cancer’s 38th Annual Meeting

September 27, 4:03 PM

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today

IOVA

2 minute read

EXCLUSIVE: Cheech & Chong’s Motto — ‘Try Anything Twice,’ Plus: Leafly, Weedmaps Embrace Digital

By Adam Eckert

September 27, 1:57 PM

Building a strong digital presence is essential for the success of cannabis brands in the modern world. Several leaders in the cannabis space discussed their approaches to digital Wednesday at the Benzinga Cannabis Capital Conference in Chicago.

LFLY

2 minute read

EXCLUSIVE: How X Is Shaping The Future Of Cannabis

By Adam Eckert

September 27, 11:31 AM

X, formerly Twitter, is the first mainstream technology platform to allow cannabis advertising. The social platform has made several policy adjustments this year to help allow the industry to grow.

TCNNF

2 minute read

Urban-Gro Secures $11M Hospitality & Recreation Contract In Southeast U.S.

By Joana Scopel

September 26, 2:11 PM

Urban-Gro, Inc. (NASDAQ: UGRO), a comprehensive professional services consulting firm announced its latest contract win within the hospitality and recreation sector in the Southeastern U.S.

UGRO

1 minute read

Ambrx To Host KOL Event Discussing ARX517 Data Presented At ESMO Congress 2023

By Benzinga Newsdesk

September 26, 8:43 AM

Ambrx Biopharma Inc., Ambrx (or the "Company") (NASDAQ:AMAM), today announced that it will host an in-person key opinion leader (KOL) event during the European Society for Medical Oncology (ESMO) Congress 2023. The event

AMAM

3 minute read

Mirum Pharmaceuticals To Highlight LIVMARLI Data From Its ALGS And PFIC Programs At The NASPGHAN Annual Meeting

By Benzinga Newsdesk

September 26, 8:41 AM

- 15 abstracts accepted for presentation showcasing LIVMARLI data from ALGS and PFIC programs- LIVMARLI PFIC primary analysis from MARCH study awarded prestigious Gerard Odell Prize for Excellence in Pediatric Hepatology

MIRM

1 minute read

Pliant Therapeutics To Host Investor Call And Webcast To Discuss Interim Results From INTEGRIS-PSC, A Phase 2a Trial In Patients With Primary Sclerosing Cholangitis

By Benzinga Newsdesk

September 25, 4:06 PM

Pliant Therapeutics, Inc. (NASDAQ:PLRX) today announced it will host a conference call and webcast on Tuesday, September 26, 2023 at 8:00 a.m. ET | 5:00 a.m. PT to discuss the interim results from the INTEGRIS-PSC

PLRX

2 minute read

Omega Therapeutics To Host Conference Call To Discuss Preliminary Clinical Data For OTX-2002 From Ongoing MYCHELANGELO I Trial On September 26

By Benzinga Newsdesk

September 25, 4:01 PM

Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will host a

OMGA

1 minute read

Kineta To Present New Preclinical Data On Lead Anti-CD27 Agonist Antibody At AACR Special Conference On Tumor Immunology And Immunotherapy

By Benzinga Newsdesk

September 25, 9:32 AM

Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present a poster on the

3 minute read

From Fast-Acting Hemp Extracts To Wiz Khalifa Mushroom Kits: Tracking Progressive Trends In Cannabis & Psychedelics

By Joana Scopel

September 22, 7:37 PM

The world of cannabis and psychedelics is evolving at a rapid pace, with companies introducing groundbreaking products and expanding into new markets.

CRLBF